Why Australian Pharmaceutical Industries Ltd (ASX:API) shares have been smashed today

The Australian Pharmaceutical Industries Ltd (ASX:API) share price has been smashed today. Here's why…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the worst performers on the market today has been the Australian Pharmaceutical Industries Ltd (ASX: API) share price.

In late morning trade the pharmacy chain operator and wholesaler's shares are down 8.5% to $1.73.

At one stage the shares of the company behind the Priceline pharmacy chain were as much as 10% lower at $1.70.

Why are Australian Pharmaceutical Industries' shares sinking lower?

With no news out of the company, it appears as though a broker note out of Credit Suisse this morning has been the catalyst for the selloff.

According to the note, the broker has downgraded Australian Pharmaceutical Industries' shares to an underperform rating from neutral and cut the price target on them from $1.63 to $1.55.

This price target implies further downside of almost 10.5% over the next 12 months for the company's shares.

Credit Suisse fears that the impressive share price rise since its Clearskincare acquisition in August means its shares are now in danger of a sharp pullback when its releases its results in October.

The company's shares recently hit a 52-week high of $1.94 on the back of its expansion into the skincare market.

Management's belief that the acquisition is highly compelling, complementary, and will lead to a more diversified business with accelerated growth potential appears to have gone down well with investors.

However, Credit Suisse doesn't think investors should get too excited just yet. Especially with the company's core business operating in a challenging environment with both PBS and retail revenues coming under pressure.

The broker believes that its shares could be de-rated next month when the full extent of the tough trading conditions are revealed.

Should you buy the dip?

While I do like that management is diversifying its business, for now I completely agree with Credit Suisse on Australian Pharmaceutical Industries and think investors would be better off staying clear of its shares until after its full year results release.

In addition to this, I think industry peer Sigma Healthcare Ltd (ASX: SIG) would be best avoided. As well as suffering from tough trading conditions, Sigma has just lost one of its biggest supply contracts. I think this earnings gap will be hard to fill.

Instead of these shares, I would consider up and coming healthcare sector peers Paragon Care Ltd (ASX: PGC) and Volpara Health Technologies Ltd (ASX: VHT).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
Share Fallers

Why Mesoblast, Navigator Global, Polynovo, and Skycity shares are falling today

These shares are having a tough finish to the week. Why are investors selling their shares?

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why Boss Energy, Core Lithium, Mesoblast, and QBE shares are falling

These ASX shares are falling. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Evolution, Galan Lithium, Life360, and Resolute shares are dropping today

These ASX shares are missing out on the good times today.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Share Fallers

Why Capricorn Metals, Core Lithium, Life360, and Mesoblast shares are dropping today

These ASX shares are having a tough time on Tuesday.

Read more »

plummeting gold share price

Own ASX gold shares? Here's why you're having a horrible day

If you own ASX gold shares, you won't be too happy right now.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Brainchip, Origin, Sayona Mining, and Stanmore shares are sinking today

These ASX shares are starting the week in the red.

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Core Lithium, Harvey Norman, TechnologyOne, and Tyro shares are dropping

These ASX shares are ending the week in the red.

Read more »

A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face as the Westpac share price goes down for no reason today
Share Fallers

Why Cettire, Lake Resources, Origin Energy, and Wildcat shares are sinking

These ASX shares are under pressure today. But why are investors hitting the sell button?

Read more »